These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18605812)

  • 1. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
    Papakostas GI; Stahl SM; Krishen A; Seifert CA; Tucker VL; Goodale EP; Fava M
    J Clin Psychiatry; 2008 Aug; 69(8):1287-92. PubMed ID: 18605812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
    Papakostas GI; Trivedi MH; Alpert JE; Seifert CA; Krishen A; Goodale EP; Tucker VL
    J Psychiatr Res; 2008 Jan; 42(2):134-40. PubMed ID: 17631898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
    Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M
    Biol Psychiatry; 2006 Dec; 60(12):1350-5. PubMed ID: 16934768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.
    Papakostas GI; Kornstein SG; Clayton AH; Soares CN; Hallett LA; Krishen A; Tucker VL
    Int Clin Psychopharmacol; 2007 Jul; 22(4):226-9. PubMed ID: 17519646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
    Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
    Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion in the treatment of outpatients with asthma and major depressive disorder.
    Brown ES; Vornik LA; Khan DA; Rush AJ
    Int J Psychiatry Med; 2007; 37(1):23-8. PubMed ID: 17645195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
    Kroenke K; Messina N; Benattia I; Graepel J; Musgnung J
    J Clin Psychiatry; 2006 Jan; 67(1):72-80. PubMed ID: 16426091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
    Papakostas GI; Fava M; Thase ME
    Biol Psychiatry; 2008 Apr; 63(7):699-704. PubMed ID: 17919460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.
    Cooper JA; Tucker VL; Papakostas GI
    J Psychopharmacol; 2014 Feb; 28(2):118-24. PubMed ID: 24352716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
    Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM
    J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression.
    Grunebaum MF; Ellis SP; Duan N; Burke AK; Oquendo MA; John Mann J
    Neuropsychopharmacology; 2012 Feb; 37(3):697-706. PubMed ID: 21993207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression.
    Nieuwstraten CE; Dolovich LR
    Ann Pharmacother; 2001 Dec; 35(12):1608-13. PubMed ID: 11793630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
    Thase ME; Haight BR; Richard N; Rockett CB; Mitton M; Modell JG; VanMeter S; Harriett AE; Wang Y
    J Clin Psychiatry; 2005 Aug; 66(8):974-81. PubMed ID: 16086611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.
    Safarinejad MR
    J Psychopharmacol; 2011 Mar; 25(3):370-8. PubMed ID: 20080928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.
    Grunebaum MF; Keilp JG; Ellis SP; Sudol K; Bauer N; Burke AK; Oquendo MA; Mann JJ
    J Clin Psychiatry; 2013 Sep; 74(9):872-9. PubMed ID: 24107760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
    McIntyre A; Gendron A; McIntyre A
    Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.